Clinical endpoints are necessary in the interim analysis of REGENERATE
Lancet
.
2020 Sep 5;396(10252):663.
doi: 10.1016/S0140-6736(20)30810-2.
Authors
Stephen Malnick
1
,
Marina Somin
2
Affiliations
1
Department of Internal Medicine, Kaplan Medical Center, Rehovot 76100, Israel. Electronic address: stephen@malnick.net.
2
Department of Internal Medicine, Kaplan Medical Center, Rehovot 76100, Israel.
PMID:
32891201
DOI:
10.1016/S0140-6736(20)30810-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Chenodeoxycholic Acid* / analogs & derivatives
Endpoint Determination
Substances
obeticholic acid
Chenodeoxycholic Acid